Literature DB >> 20425525

Cutaneous manifestations of dermatomyositis and their management.

Jeffrey P Callen1.   

Abstract

Dermatomyositis is a condition with pathognomonic and characteristic cutaneous lesions. This article describes the skin manifestations observed in patients with dermatomyositis, their differential diagnosis, their relationship to internal disease (particularly malignancy), and their management.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20425525     DOI： 10.1007/s11926-010-0100-7

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN： 1523-3774            Impact factor:   4.592


  24 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

2.  Leflunomide as a remission-maintaining therapy in difficult-to-treat dermatomyositis.

Authors:  V S Sangle; S R Sangle; D P D'Cruz
Journal:  Ann Rheum Dis       Date:  2008-05       Impact factor: 19.103

3.  Mycophenolate mofetil as an effective corticosteroid-sparing therapy for recalcitrant dermatomyositis.

Authors:  Johnathon C Edge; J David Outland; Jennifer R Dempsey; Jeffrey P Callen
Journal:  Arch Dermatol       Date:  2006-01

4.  Improvement in dermatomyositis rash associated with the use of antiestrogen medication.

Authors:  Danya Sereda; Victoria P Werth
Journal:  Arch Dermatol       Date:  2006-01

5.  Clinically amyopathic dermatomyositis: what can we now tell our patients?

Authors:  Richard D Sontheimer
Journal:  Arch Dermatol       Date:  2010-01

6.  The immunofluorescent profile of dermatomyositis: a comparative study with lupus erythematosus.

Authors:  C M Magro; A N Crowson
Journal:  J Cutan Pathol       Date:  1997-10       Impact factor: 1.587

7.  Adverse cutaneous reactions to hydroxychloroquine are more common in patients with dermatomyositis than in patients with cutaneous lupus erythematosus.

Authors:  Michelle T Pelle; Jeffrey P Callen
Journal:  Arch Dermatol       Date:  2002-09

8.  Dermatomyositis: comparative studies of cutaneous photosensitivity in lupus erythematosus and normal subjects.

Authors:  L Dourmishev; H Meffert; H Piazena
Journal:  Photodermatol Photoimmunol Photomed       Date:  2004-10       Impact factor: 3.135

9.  Comparison of the reliability and validity of outcome instruments for cutaneous dermatomyositis.

Authors:  R Q Klein; C A Bangert; M Costner; M K Connolly; A Tanikawa; J Okawa; M Rose; S S Fakharzadeh; D Fiorentino; L A Lee; R D Sontheimer; L Taylor; A B Troxel; V P Werth
Journal:  Br J Dermatol       Date:  2008-07-04       Impact factor: 9.302

10.  A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis.

Authors:  M C Dalakas; I Illa; J M Dambrosia; S A Soueidan; D P Stein; C Otero; S T Dinsmore; S McCrosky
Journal:  N Engl J Med       Date:  1993-12-30       Impact factor: 91.245
View more
  13 in total

1.  Diagnosis and treatment of the idiopathic inflammatory myopathies.

Authors:  David J Gazeley; Mary E Cronin
Journal:  Ther Adv Musculoskelet Dis       Date:  2011-12       Impact factor: 5.346

2.  Panniculitis as an Initial Presentation of Dermatomyositis: A Case Report.

Authors:  Anjal Bisht; Niraj Parajuli; Monasha Vaidya; Sumida Tiwari
Journal:  JNMA J Nepal Med Assoc       Date:  2020-03       Impact factor: 0.406

Review 3.  Cutaneous Manifestations of Dermatomyositis: a Comprehensive Review.

Authors:  Carlo Mainetti; Benedetta Terziroli Beretta-Piccoli; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2017-12       Impact factor: 8.667

Review 4.  [Dermatomyositis and juvenile dermatomyositis].

Authors:  Frank Dressler; Britta Maurer
Journal:  Z Rheumatol       Date:  2022-04-29       Impact factor: 1.372

5.  Gottron's papules exhibit dermal accumulation of CD44 variant 7 (CD44v7) and its binding partner osteopontin: a unique molecular signature.

Authors:  Jessica S Kim; Muhammad M Bashir; Victoria P Werth
Journal:  J Invest Dermatol       Date:  2012-03-29       Impact factor: 8.551

6.  Lasting pathologic complete response to chemotherapy for ovarian cancer after receiving antimalarials for dermatomyositis.

Authors:  Isabella Cadena; Victoria P Werth; Pascale Levine; Annie Yang; Andrea Downey; John Curtin; Franco Muggia
Journal:  Ecancermedicalscience       Date:  2018-05-22

7.  Reclassification of Korean patients with polymyositis and dermatomyositis based on the Bohan and Peter criteria by the 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies.

Authors:  Juyoung Yoo; Sung Soo Ahn; Seung Min Jung; Jason Jungsik Song; Yong-Beom Park; Sang-Won Lee
Journal:  Korean J Intern Med       Date:  2019-12-30       Impact factor: 2.884

8.  Identification of Latent Diagnostic Biomarkers and Biological Pathways in Dermatomyositis Based on WGCNA.

Authors:  Shaxi Ouyang; Yifang Liu; Changjuan Xiao; Qinghua Zeng; Xun Luo; Xiaofang Hu; Shuoshan Xie
Journal:  J Oncol       Date:  2021-12-30       Impact factor: 4.375

9.  Hemophagocytic Syndrome Complicated with Dermatomyositis Controlled Successfully with Infliximab and Conventional Therapies.

Authors:  Yoji Komiya; Tetsuya Saito; Fumitaka Mizoguchi; Hitoshi Kohsaka
Journal:  Intern Med       Date:  2017-12-01       Impact factor: 1.271

10.  Ground-glass opacity heralding invasive lung adenocarcinoma with prodromal dermatomyositis: a case report.

Authors:  Andrew J Beel; David S Demos; Alfred Chung; Charles Liao; Natalie S Lui
Journal:  J Cardiothorac Surg       Date:  2018-02-07       Impact factor: 1.637
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.